has listed some key points that would concern global pharmaceutical enterprises. Set up a China GVP Project Team The legal representative or main responsible person of the MAH (marketing authorization holder) also known as China “QPPV”– Qualified Person for Pharmacovigilance shall be fully responsi...
The study also gives insight on understanding the mode of entry adopted by Indian companies with special reference to the Himalaya Drug Company. The study takes a multistage approach through secondary data analysis, an interpretative approach, and interviews of 15 pharmaceutical personnel and 30 ...
aone knows how many U.S. mental patients qualify for it: the figure most often quoted is around 100,000’ (Time 1970). The retired executives I interviewed concurred that pharmaceutical companies were viewed appreciatively. 你知道多少美国。 精神病患者在它合格: 经常被引述的figure是大约100,...
“There's insufficient work being done on that. It's not integrated early enough in the development cycle and all the way through the process to effectively craft an amenable commercial strategy and access strategy.” Additionally, Ford explained that sometimes pharmaceutical companies miscalculate what...
Transparency in communicating potential supply disruptions 5. Environmental and Social Responsibility Increasingly, pharmaceutical companies are recognizing the importance of partnering with suppliers who prioritize sustainability and ethical practices. Look for suppliers who: ...
However, pharmaceutical companies may find a series of challenges when seeking market access: Limited knowledge of the regulations in the target market; Unfamiliarity with the procurement, pricing, and reimbursement policies; Inadequate understanding of supply chains and...
This can make it difficult to see the collective impact of the pharmaceutical supply chain on the environment. However, there are many trailblazers in the industry who are leading the way in changing the status quo and creating a more sustainable pharma supply chain. There are multiple ways ...
China’s biopharma industry already has considerable strengths (Exhibit 1). One obvious strength is in manufacturing, with China-produced active pharmaceutical ingredients supplying most important global markets. The fast ramp-up in other modalities, such as antibodies, is another ...
It is also advisable to delegate the responsibility of managing and overseeing the use of the company chop to more than one employee to avoid giving too much power to one individual. Many foreign companies in China will often give the responsibility of managing the company chop to one employee...
Ultimately, the main objective of pharmaceutical companies when pricing drugs is to generate the most revenue. This often means facing competition, which serves to drive prices lower. However, drug companies have balanced pricing drugs too low with the ability to enact price increases at steady inte...